Sales and Marketing

Showing 15 posts of 11527 posts found.

Clinical evidence revisited

May 18, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Lord Saatchi, Medical Innovation Bill, clinical trials

One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …

Heartbreak for Novartis as FDA rejects drug

May 18, 2014 Research and Development, Sales and Marketing GSK, Novartis, heart drug

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …

AstraZeneca signs UK research deal

May 16, 2014 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer

The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …

Roche gets oncology boost with cancer vaccine

May 16, 2014 Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology

Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …

Giotrif increases lung cancer survival

May 16, 2014 Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer

Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …

AstraZeneca lung cancer data reveals promise

May 15, 2014 Sales and Marketing ASCO, AstraZeneca, NSCLC, azd0291, lung cancer

AstraZeneca has released promising data in a lung cancer trial with one of its investigational drugs, AZD9291, which has breakthrough …

Scrap ‘iniquitous and outdated’ NHS prescription charges

May 15, 2014 Sales and Marketing BMJ, NHS, charges, dab, drugs, prescription

The NHS prescription charge is iniquitous and outdated and needs to be scrapped, according to an editorial in the Drug …

K-V Pharmaceutical hires head of women’s healthcare

May 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KV, paul williams

K-V Pharmaceutical (KV) has hired industry veteran and former Actavis head Paul Williams to lead its women’s healthcare division.  Williams …

MedImmune signs Incyte oncology deal

May 15, 2014 Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology

MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …

Pfizer: ‘fewer scientists’ after merger

May 14, 2014 Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover

Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …

More late-stage anguish for GSK heart drug

May 14, 2014 Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart

GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …

GSK China head arrested over bribery charges

May 14, 2014 Medical Communications, Sales and Marketing China, GSK, bribery, pharma, reilly

A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …

Pfizer grilled by MPs – but AZ revelations shock

May 14, 2014 Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover

The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …

Just:: appoints digital specialist

May 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Prideaux, Just, Just::, digital

Just:: Health Communications has hired Daniel Prideaux to head-up its digital offering.  Prideaux joins from DigitasLBi and previously worked at …

NICE: no early Zytiga use

May 14, 2014 Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate

Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …
The Gateway to Local Adoption Series

Latest content